FEN1 and cervical cancer: Our results showed that FEN1 inhibitor enhances IR sensitivity of cervical cancer both in vitro and in vivo, which confirmed the conclusion that inhibition of FEN1 can sensitize cancer cells to DNA damage‐related drugs.